Title:
ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF BINDING TO HUMAN CD39, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/078381
Kind Code:
A1
Abstract:
The present invention belongs to the technical field of tumor treatment, and specifically relates to an antibody or an antigen binding fragment thereof that bind to human CD39, and a preparation method therefor and the use thereof. The antibody or the antigen-binding fragment thereof of the present invention that bind to human CD39 can effectively bind to human CD39, and can be used in the preparation of a drug for treating diseases characterized by the over-expression of CD39, thus having a good clinical prospect.
Inventors:
HUANG HAOMIN (CN)
ZHANG XUESAI (CN)
XU FEI (CN)
DENG LAN (CN)
ZHANG XUESAI (CN)
XU FEI (CN)
DENG LAN (CN)
Application Number:
PCT/CN2023/123176
Publication Date:
April 18, 2024
Filing Date:
October 07, 2023
Export Citation:
Assignee:
SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD (CN)
International Classes:
C07K16/28; A61K39/00; A61K39/395; A61P35/00; C12N5/10; C12N15/13; C12N15/63
Foreign References:
| CN112714768A | 2021-04-27 | |||
| CN114773473A | 2022-07-22 | |||
| CN114651013A | 2022-06-21 | |||
| CN114729038A | 2022-07-08 |
Attorney, Agent or Firm:
J.Z.M.C. PATENT AND TRADEMARK LAW OFFICE (GENERAL PARTNERSHIP) (CN)
Download PDF: